Persistent SARS-CoV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID
A Vojdani, E Vojdani, E Saidara, M Maes - Viruses, 2023 - mdpi.com
A novel syndrome called long-haul COVID or long COVID is increasingly recognized in a
significant percentage of individuals within a few months after infection with SARS-CoV-2 …
significant percentage of individuals within a few months after infection with SARS-CoV-2 …
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and …
DB Kell, E Pretorius - Biochemical Journal, 2022 - portlandpress.com
Ischaemia–reperfusion (I–R) injury, initiated via bursts of reactive oxygen species produced
during the reoxygenation phase following hypoxia, is well known in a variety of acute …
during the reoxygenation phase following hypoxia, is well known in a variety of acute …
Effect of using a structured pacing protocol on post‐exertional symptom exacerbation and health status in a longitudinal cohort with the post‐COVID‐19 syndrome
M Parker, HB Sawant, T Flannery… - Journal of Medical …, 2023 - Wiley Online Library
Post‐exertional symptom exacerbation (PESE) is a characteristic symptom of post‐COVID
syndrome (PCS). This prospective study investigated the effect of a 6‐week structured World …
syndrome (PCS). This prospective study investigated the effect of a 6‐week structured World …
[HTML][HTML] Molecular mechanisms of neuroinflammation in ME/CFS and long COVID to sustain disease and promote relapses
W Tate, M Walker, E Sweetman, A Helliwell… - Frontiers in …, 2022 - frontiersin.org
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disease now well-
documented as having arisen commonly from a viral infection, but also from other external …
documented as having arisen commonly from a viral infection, but also from other external …
Role of SARS-CoV-2 spike-protein-induced activation of microglia and mast cells in the pathogenesis of neuro-COVID
TC Theoharides, D Kempuraj - Cells, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). About 45% of COVID-19 patients experience several symptoms a …
disease 2019 (COVID-19). About 45% of COVID-19 patients experience several symptoms a …
Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles
T Aschman, E Wyler, O Baum, A Hentschel… - Acta Neuropathologica …, 2023 - Springer
The SARS-CoV-2 pandemic not only resulted in millions of acute infections worldwide, but
also in many cases of post-infectious syndromes, colloquially referred to as “long COVID” …
also in many cases of post-infectious syndromes, colloquially referred to as “long COVID” …
Health equity, care access and quality in headache–part 1
C Tana, B Raffaelli, MNP Souza, ER de la Torre… - The Journal of …, 2024 - Springer
Current definitions of migraine that are based mainly on clinical characteristics do not
account for other patient's features such as those related to an impaired quality of life, due to …
account for other patient's features such as those related to an impaired quality of life, due to …
A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
Background Post-acute COVID-19 syndrome (PACS) affects over 65 million individuals
worldwide but treatment options are scarce. We aimed to assess a synbiotic preparation …
worldwide but treatment options are scarce. We aimed to assess a synbiotic preparation …
A scoping review of 'Pacing'for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic
NEM Sanal-Hayes, M Mclaughlin, LD Hayes… - Journal of translational …, 2023 - Springer
Background Controversy over treatment for people with myalgic encephalomyelitis/chronic
fatigue syndrome (ME/CFS) is a barrier to appropriate treatment. Energy management or …
fatigue syndrome (ME/CFS) is a barrier to appropriate treatment. Energy management or …
[HTML][HTML] The pathobiology of myalgic encephalomyelitis/chronic fatigue syndrome: the case for neuroglial failure
H Renz-Polster, ME Tremblay, D Bienzle… - Frontiers in cellular …, 2022 - frontiersin.org
Although myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has a specific and
distinctive profile of clinical features, the disease remains an enigma because causal …
distinctive profile of clinical features, the disease remains an enigma because causal …